Published Jun 27, 2022

The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Podcast #78

Andrew Huberman delves into the complexities of OCD, examining its neural mechanisms and differentiating it from OCPD, while exploring both behavioral and pharmacological treatments. The episode presents a comprehensive analysis of therapies like CBT and exposure therapy, alongside discussions on SSRIs and emerging treatments such as ketamine and cannabis.
Episode Highlights
Huberman Lab logo

Popular Clips

Questions from this episode

Episode Highlights

  • Neural Circuitry

    The cortico-striatal-thalamic loop is a crucial neural circuit implicated in OCD, influencing the repetitive thought-action loops characteristic of the disorder. explains that while SSRIs can suppress the activity of this loop, they do not work for everyone and come with side effects 1. Animal studies have demonstrated that stimulating this circuit can induce OCD-like behaviors, highlighting its central role in the disorder 2.

    The cortico-striatal-thalamic circuit seems to be the main circuit generating OCD-like behavior.

    --- Andrew Huberman

    Understanding this loop helps in tailoring treatments, as different therapies target various components of this circuit 3.

       

    Neurotransmitters

    Neurotransmitters, particularly serotonin, play a complex role in OCD treatment. Despite SSRIs being effective for some, there's little evidence that serotonin disruption causes OCD 4. notes that SSRIs like fluoxetine and sertraline work by increasing serotonin in the synapse, but their side effects vary widely among individuals 5.

    There is very little, if any evidence, that the serotonin system is disrupted in OCD.

    --- Andrew Huberman

    This underscores the importance of personalized treatment plans and ongoing research into alternative therapies like psilocybin, which targets serotonin receptors but has yet to show conclusive results for OCD 4.

Related Episodes